Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03159195 · ClinicalTrials.gov registry record
Ibrance Real World Insights
A clinical trial, sponsored by Pfizer.
- Completed
- Registry status
- 652
- Enrollment target
NCT03159195 is a clinical trial that has completed, run by Pfizer. The registered enrollment target is 652 participants.
The verdict
NCT03159195 has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- 652 participants
- Enrollment target
Study Summary
To describe patient demographics, clinical characteristics, treatment patterns and clinical outcomes of adult female patients who have received palbociclib combination treatments in line with regional licensed indications in real world settings across multiple countries.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 652 participants |
| Start Date | 2017-06-12 |
| Est. Completion | 2021-06-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03159195
The ClinicalTrials.gov registry entry for NCT03159195 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 652 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03159195 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03159195 about?
NCT03159195 is a clinical study titled "Ibrance Real World Insights". To describe patient demographics, clinical characteristics, treatment patterns and clinical outcomes of adult female patients who have received palbociclib combination treatments in line with regional licensed indications in real world settings across multiple countries.
What is the current status of trial NCT03159195?
This trial is currently completed. The enrollment target is 652 participants. The study started on 2017-06-12. Estimated completion is 2021-06-24.
Who is sponsoring clinical trial NCT03159195?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.